AMP Corporate Workshop Day has now gone virtual! Take advantage of over 70 workshops on the AMP Virtual platform starting the week of November 16th. Workshops are accessible onDemand within the virtual platform for all meeting registrants! Make sure you also plan to attend a the LIVE workshops which will include a Q&A portion with the speakers - schedule below! Be sure to also download the program for a COMPLETE listing of the workshops (LIVE & onDemand)!
Monday, November 16, 2020 |
|
| 4:00pm - 5:00pm | Illumina Presents: Flexible Capabilities to Enable Comprehensive Genomic Profiling |
| 4:00pm - 5:00pm | Bayer Presents: A non-CME Webinar Presentation on NTRK Gene Fusions in Oncology |
| 4:00pm - 5:00pm | Thermo Fisher Presents: Responding to the COVID-19 Outbreak: Global Clinical Performance and Development of the Applied Biosystems TaqPath COVID-19 Assay |
| 4:00pm - 5:00pm | Eli Lilly and Company Presents: Testing for RET: A Pathologist Perspective |
Wednesday, November 18, 2020 |
|
| 3:30pm - 4:30pm | Illumina Presents: Comprehensive Genomic Profiling from Liquid Biopsy Samples |
| 3:30pm - 4:30pm | Thermo Fisher Presents: Advances in NGS Automation Accelerates Time to Results for Myeloid and Comprehensive Genomic Profiling |
| 3:30pm - 4:30pm | AccuGenomics Presents: SNAQ-SEQ Internal QC Standards: Powerful Tools to Improve the Accuracy of NGS-based Assays |
| 3:30pm - 4:30pm | ArcherDX Presents: Circulating Tumor DNA Assay For Monitoring Disease Progression |
Wednesday, November 18, 2020 |
|
| 4:30pm - 5:30pm | LGC Seracare Presents: Technical Challenges Advancing NGS ctDNA Testing to MRD and bTMB |
| 4:30pm - 5:30pm | Oxford Gene Techology Presents: Implementing SureSeq Myeloid and CLL Panels for Comprehensive Genomic Profiling of Haematological Malignancies |
| 4:30pm - 5:30pm | Canexia Health Presents: Making the Case for Bringing Precision Oncology Testing In-house In Complex Healthcare Systems |
| 4:30pm - 5:30pm |
Thermo Fisher Presents: Scaling COVID-19 Testing: High-Throughput, Highly Automated COVID-19 Testing with the new Thermo Fisher Scientific™ Amplitude™ Solution |
| 10x Genomics |
| AccuGenomics, Inc |
| Agena Bioscience |
| Agilent Technologies |
| Amgen |
| ArcherDx |
| AstraZeneca |
| Asuragen |
| ATCC |
| Biocartis |
| Biolyph Bionano Genomics |
| Bio-Rad Laboratories, Inc. |
| BioView (USA) Inc. |
| Cepheid |
| ChromaCode |
| Cofactor Genomics |
| COMBiNATi |
| Contextual Genomics |
| DiaSorin Molecular |
| Fabric Genomics |
| Foundation Medicine, Inc |
| GenMark Diagnostics |
| Illumina |
| Integrated DNA Technologies |
| Invivoscribe |
| LGC Clinical Diagnostics |
| LGC, Biosearch Technologies |
| Luminex |
| Meridian BioScience Inc. |
| Molecular Health |
| NanoString Technologies |
| Oxford Gene Technology |
| Personal Genome Diagnostics |
| PierianDx |
| Pillar Biosciences Inc. |
| Promega Corporation |
| Purigen Biosystems, Inc. |
| QIAGEN |
| Rheonix, Inc. |
| Roche |
| Sophia Genetics |
| STEMCELL Technologies, Inc. |
| Thermo Fisher Scientific |
| Twist Bioscience |
| PerkinElmer |
Disclaimer: Corporate Workshops are commercial activities. Workshop content and associated materials, including but not limited to workshop descriptions, promotional messages and handouts are the sole responsibility of the commercial entity presenting the workshop (Host Company). AMP does not endorse any commercial product or service. AMP does not review the content of commercial activities. AMP makes no warranty, express or implied, regarding any commercial product or service, and hereby disclaims, the accuracy, completeness, timeliness or merchantability or fitness for a particular purpose of the workshop content and associated materials. AMP shall not be liable for any damages, including direct, indirect, special, incidental, or consequential or any other type of damages arising out of or related to the use of the information contained in the workshop or associated materials.